⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001457395

Karan Shashi K.

Reports to the SEC for 1 company · SEATTLE, WA

Transactions

7

Companies

1

Filings

5

CIK

0001457395

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-09-28	Cascadian Therapeutics, Inc.P Purchase	Corporate Controller	PPurchase	+5,100 sh	$3.41	+$17.4K	10,100
2009-12-03	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Corporate Controller	AAward	+50K sh	—	—	50,000
2009-08-18	Cascadian Therapeutics, Inc.P Purchase	Corporate Controller	PPurchase	+1,200 sh	$5.05	+$6,060	1,200
2009-08-18	Cascadian Therapeutics, Inc.P Purchase	Corporate Controller	PPurchase	+100 sh	$5.07	+$507	1,300
2009-08-18	Cascadian Therapeutics, Inc.P Purchase	Corporate Controller	PPurchase	+3,700 sh	$5.08	+$18.8K	5,000
2009-03-11	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Corporate Controller	AAward	+7,500 sh	—	—	7,500
2009-03-11	Cascadian Therapeutics, Inc.Stock Option (right to buy)A Award	Corporate Controller	AAward	+7,500 sh	—	—	7,500

Recent filings

5

Accepted (ET)
Sep 294
Karan Shashi K.0001457395-10-000001
SEC(opens sec.gov)
Dec 44
Karan Shashi K.0001457395-09-000006
SEC(opens sec.gov)
Aug 184
Karan Shashi K.0001457395-09-000005
SEC(opens sec.gov)
Mar 184/A
Karan Shashi K.0001457395-09-000004
SEC(opens sec.gov)
Mar 114
Karan Shashi K.0001242122-09-000003
SEC(opens sec.gov)

Companies

1

Cascadian Therapeutics, Inc.Corporate Controller

Address

2601 FOURTH AVENUE SUITE 500

SEATTLE, WA, 98121